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Abstract
The goal of the research in this dissertation is to develop detection methods for
neurochemicals towards achieving early neurological disease diagnosis. Ideally, the detection
methods in physiologically relevant ranges are rapid, selective, label-free, and sensitive. Our
approach is Raman spectroscopy, a light scattering technique that provides information about the
vibrational modes of a system through interaction with a monochromatic light source. Raman
scattering results in a molecular fingerprint for each species, however it is inherently weak. To
enhance the Raman signal, we use the localized surface plasmon resonance (LSPR), which arises
from the collective oscillation of surface conduction electrons of a metal nanoparticle when
excited with a laser, resulting in an enhanced electric field. When a molecule is adsorbed on the
nanoparticle surface, the excited Raman scattering is enhanced by the LSPR, and referred to as
surface-enhanced Raman spectroscopy (SERS). SERS permits the detection of low concentration
analytes. Here we discuss optimization of SERS substrates and excitation wavelength for low
concentration detection of neurochemicals. This comprehensive study involved detection of
neurotransmitters on both silver and gold nanoparticles at 3 different excitation wavelengths to
determine ideal conditions for detection.
SERS can also be combined with spatially offset Raman spectroscopy (SORS), termed
SESORS, to detect low concentration analytes in subsurface layers of diffusely scattering media.
SORS takes advantage of the spatial component of light in which the photons that travel deeper
into the material traverse laterally before being scattered out at the surface. By collecting the
Raman scattered light at a point that is spatially offset from the incident illumination point, signal
can be obtained from the deep layers. SESORS was used to detect neurotransmitters in a brain
tissue mimic through an animal skull. Initial experiments involved optimization of the volume
and order of the addition of the SERS probe as well as determining the optimal offset needed for
the skull. These experiments were followed by finding limits of detection of various
iv

neurotransmitters through the skull including melatonin, serotonin, dopamine, epinephrine, and
norepinephrine, as well as determining the feasibility of this technique for an in vivo detection
technique using a mouse model.

v

Table of Contents
Chapter 1 General Introduction .................................................................................................. 1
1.1 References ............................................................................................................................ 5
Chapter 2 Raman Spectroscopy and Instrumentation .............................................................. 8
2.1 Raman Spectroscopy ........................................................................................................... 9
2.1.1 Introduction .................................................................................................................. 9
2.1.2 Theory .......................................................................................................................... 10
2.2 Surface Enhanced Raman Spectroscopy (SERS) ........................................................... 15
2.2.1 Introduction ................................................................................................................ 15
2.2.2 Mechanism of SERS ..................................................................................................... 15
2.2.3 Nanoparticle Synthesis ................................................................................................. 19
2.3 Spatially Offset Raman Spectroscopy (SORS) ............................................................... 23
2.3.1 Mechanism of SORS .................................................................................................... 23
2.3.2 Collection Geometry..................................................................................................... 25
2.4 Instrumentation ................................................................................................................. 28
2.4.1 Introduction .................................................................................................................. 28
2.4.2 Excitation Sources ........................................................................................................ 28
2.4.3 Sample Delivery and Collection System ...................................................................... 29
2.4.4 Spectrograph ................................................................................................................. 30
2.4.5 Detectors ....................................................................................................................... 32
2.4.6 Raman Systems Built in the Sharma Lab ..................................................................... 33
2.5 Spectral Analysis ............................................................................................................... 38
2.5 References .......................................................................................................................... 42
Chapter 3 Multi-metal, multi-wavelength surface-enhanced Raman spectroscopy detection
of neurotransmitters ................................................................................................................... 46
3.1 Abstract .............................................................................................................................. 47
3.2 Introduction ....................................................................................................................... 47
3.3 Experimental Section ........................................................................................................ 49
3.3.1 Materials and Reagents ................................................................................................. 49
3.3.2 Preparation of silver and gold nanoparticles ................................................................ 50
3.3.3 SERS Sample Preparation ............................................................................................ 50
3.3.4 Raman Spectroscopy .................................................................................................... 50
3.4 Results and Discussion ...................................................................................................... 51
3.5 Conclusions ........................................................................................................................ 82
3.6 Acknowledgements ............................................................................................................ 82
3.7 References .......................................................................................................................... 83
Chapter 4 Surface Enhanced Spatially Offset Raman Spectroscopy detection of
Neurochemicals Through the Skull ........................................................................................... 88
4.1 Abstract .............................................................................................................................. 89
4.2 Introduction ....................................................................................................................... 89
4.3 Results and Discussion ...................................................................................................... 91
4.4 Conclusion ........................................................................................................................ 100
4.5 Acknowledgements .......................................................................................................... 102
vi

4.6 References ........................................................................................................................ 103
Chapter 5 In vivo Detection of Neurochemicals in a Mouse Brain Through the Skull with
Surface-Enhanced Spatially Offset Raman Spectroscopy .................................................... 107
5.1 Abstract ............................................................................................................................ 108
5.2 Introduction ..................................................................................................................... 108
5.3 Experimental Section ...................................................................................................... 110
5.3.1 Materials ..................................................................................................................... 110
5.3.2 Nanoparticle Synthesis ............................................................................................... 111
5.3.3 Preparation of Agarose Gels for SESORS Measurements ......................................... 111
5.3.4 Raman Spectroscopy, SERS, & SESORS .................................................................. 111
5.3.5 Dark Field Imaging ..................................................................................................... 112
5.3.6 Mouse Model .............................................................................................................. 112
5.4 Results and Discussion .................................................................................................... 113
5.5 Conclusion ........................................................................................................................ 127
5.6 Acknowledgements .......................................................................................................... 128
5.7 References ........................................................................................................................ 129
Chapter 6 Electrochemical Surface-Enhanced Raman Spectroscopy for the Selective
Identification of Dopamine and Metabolites .......................................................................... 133
6.1 Abstract ............................................................................................................................ 134
6.2 Introduction ..................................................................................................................... 134
6.3 Experimental Section ...................................................................................................... 137
6.3.1 Reagents and Materials ............................................................................................... 137
6.3.2 Preparation of AuNPs ................................................................................................. 137
6.3.3 Preparation of SERS-Active Electrodes ..................................................................... 138
6.3.4 SERS Measurements .................................................................................................. 138
6.3.5 Spectroelectrochemical Measurements ...................................................................... 139
6.4 Results and Discussion .................................................................................................... 139
6.5 Conclusion ........................................................................................................................ 148
6.6 Acknowledgements .......................................................................................................... 150
6.7 References ........................................................................................................................ 151
Chapter 7 Conclusion and Future Directions ........................................................................ 159
Vita ............................................................................................................................................. 162

vii

List of Tables
Table 3.1A-G: Peak positions, chemical structure, and LODs of neurotransmitters on AuNPs
and AgNPs at an excitation wavelength of 532 nm, 633 nm, and 785 .................................... 57-63
Table 5.1 Peak positions associated with specified vibrational modes as well as the chemical
structures of serotonin and melatonin ..........................................................................................118
Table 5.2 Peak positions associated with specified vibrational modes as well as the chemical
structures of dopamine, norepinephrine, and epinephrine ...........................................................121
Table 6.1 Band assignments for the SERS shifts of dopamine, DOPAC, HVA, and 3-O-MD as
well as chemical structures for each neurotransmitter .................................................................142
Table 6.2 Normal brain concentrations as well as limits of detection for dopamine, DOPAC,
HVA, and 3-O-MD in H2O, artificial urine, and aCSF ...............................................................143

viii

List of Figures
Figure 2.1: Jablonski diagram representing Rayleigh and Raman scattering ...............................12
Figure 2.2: Typical Raman spectrum of a common Raman reporter molecule, benzenethiol .....14

..........................................

.............................................................................................
Figure 2.5: Schematic of SORS describing the pathway of photons deep in the material before
scattering from the surface .............................................................................................................24
Figure 2.6: SORS geometries of a point collection (A), conventional SORS (B), inverse SORS
(C), transmission Raman (D), and micro-SORS (E)......................................................................27
Figure 2.7: Schematic of a Czerny-Turner Monochromator with an entrance and exit slit,
directing and collimating mirrors, and a grating ............................................................................31
Figure 2.8: Macroscopic Raman system built in the Sharma Lab ................................................34
Figure 2.9: Macroscopic Raman system built in the Sharma Lab ................................................36
Figure 2.10: Placement of the axicon into the optical set-up of the macroscopic Raman system to
create a spatial offset for SORS measurements .............................................................................37
Figure 2.11: UV Laser purchased from photonics industries .......................................................39
Figure 2.12: UV optics used to direct the light onto the sample ..................................................40
Figure 2.13: Pathway of Raman scattered light into the spectrometer .........................................41
Figure 3.1: SEM images of AuNPs (A) and AgNPs (B) used for SERS detection ......................52
Figure 3.2: Solid spectra of melatonin (blue), serotonin (red), glutamate (green), dopamine
(purple), GABA (pink), norepinephrine (orange), and epinephrine (black) .................................53

ix

..........................................................................
Figure 3.4: SERS spectra of melatonin (blue), serotonin (red), glutamate (green), dopamine
(purple), GABA (pink), norepinephrine (orange), and epinephrine (black) on AuNPs (A) and
......................................................................................................................64

..................................................................
Figure 3.6: Scores on PC1 plotted against scores on PC2 (A) of concentrations from 100 nM to
1 nM and their accompanying loadings (B,C) for the SERS spectra of melatonin (blue), serotonin
(red), dopamine (purple), norepinephrine (orange), and epinephrine (black) on AuNPs ..............66
Figure 3.7: PCA plots for SERS spectra taken at 633 nm on AgNPs. Scores on PC1 plotted

loadings (B, C) and scores on PC1 plotted against scores on PC3 (D) of concentrations of 800
nM to 100 nM and their accompanying loadings (E, F) ................................................................70
Figure 3.8: Scores on PC1 plotted against scores on PC2 (A) of concentrations from 100 nM to
1 nM and their accompanying loadings (B,C) for the SERS spectra of melatonin (blue), serotonin
(red), glutamate (green), dopamine (purple), GABA (pink), norepinephrine (orange), and
epinephrine (black) on AgNPs .......................................................................................................71
Figure 3.9: SERS spectra of melatonin (blue), serotonin (red), glutamate (green), dopamine
(purple), GABA (pink), norepinephrine (orange), and epinephrine (black) on AuNPs (A) and
AgNPs (B) at 5

......................................................................................................................72

x

Figure 3.10: PCA plots for SERS spectra taken at 785 nm on AuNPs. Scores on PC1 plotted

loadings (C, D) and Scores on PC2 plotted against scores on PC5 (E) of concentrations of 800
nM to 100 nM and their accompanying loadings (F, G)................................................................73
Figure 3.11: Scores on PC1 plotted against scores on PC2 (A) of concentrations from 100 nM to
1 nM and their accompanying loadings (B,C) for the SERS spectra of melatonin (blue), serotonin
(red), dopamine (purple), norepinephrine (orange), and epinephrine (black) on AuNPs ..............74
Figure 3.12: PCA plots for SERS spectra taken at 785 nm on AgNPs. Scores on PC1 plotted

loadings (C, D) and Scores on PC1 plotted against scores on PC2 (E) of concentrations of 800
nM to 100 nM and their accompanying loadings (F, G)................................................................75
Figure 3.13:
800 nM and their accompanying loadings (B,C) for the SERS spectra of melatonin (blue),
dopamine (purple), GABA (pink), norepinephrine (orange), and epinephrine (black) on
AgNPs ............................................................................................................................................76
Figure 3.14: Scores on PC1 plotted against scores on PC2 (A) of concentrations from 800 nM to
100 nM and their accompanying loadings (B,C) for the SERS spectra of melatonin (blue),
dopamine (purple), GABA (pink), norepinephrine (orange), and epinephrine (black) on
AgNPs ............................................................................................................................................77
Figure 3.15: Scores on PC1 plotted against scores on PC2 (A) of concentrations from 100 nM to
1 nM and their accompanying loadings (B,C) for the SERS spectra of melatonin (blue), serotonin
(red), glutamate (green), dopamine (purple), GABA (pink), norepinephrine (orange), and
epinephrine (black) on AgNPs .......................................................................................................78
Figure 3.16: Integrated intensities, corrected for laser power and accumulation time .................79

xi

Figure 3.17: SERS spectra of melatonin (blue), serotonin (red), dopamine (purple),
nore
(B) ..................................................................................................................................................81
Figure 4.1: SERS spectra of (A) melatonin, (B) epinephrine, and (C) serotonin at concentrations
of 100 µM (blue), 10 µM (red), 1 µM (green), and 100 nM (purple)............................................93
Figure 4.2: Diffuse reflectance (A) and transmittance (B) spectra of four animal skulls.............94
Figure 4.3: SESORS spectra of benzenethiol through the skull ...................................................95
Figure 4.4: SESORS spectra of melatonin (A, D), epinephrine (B, E), and serotonin (C, F) at
concentrations of 50 mM (top row) and 100 µM (bottom row) ....................................................97
Figure 4.5: Scores of PC1 plotted against scores of PC2 with a PCA applied to the data with no
spatial offset and a 2 mm spatial offset (A) along with the loadings from PC1 (B) and PC2
(C) ..................................................................................................................................................99
Figure 4.6: Scores of PC2 plotted against scores of PC4 with PCA applied to the subtracted
data ...............................................................................................................................................101
Figure 5.1. Dark field scattering images of the top, middle, and bottom of an agarose gel infused
with AuNPs ..................................................................................................................................114
Figure 5.2. Schematic of the geometry of Teflon, agarose gel, and bone used for the depth study
(A) and the heat map of the SORS detection depth of Teflon using a spatial offset of 2 mm
(B). ...............................................................................................................................................116
Figure 5.3. Heat map of the SESORS spectra for the LOD of serotonin (A) and melatonin (B)
through a rat skull using a spatial offset of 2 mm ........................................................................119
Figure 5.4. Heat map of the SESORS spectra for the LOD of dopamine (A), norepinephrine (B),
and epinephrine (C) through a rat skull using a spatial offset of 2 mm .......................................122

xii

Figure 5.5. SESORS spectra of mixtures containing melatonin and serotonin (A), dopamine,
epinephrine and norepinephrine (B), and dopamine, GABA, and DOPAC (C) ..........................124
Figure 5.6. SORS spectra of the mouse brain through the skull without the injection of serotonin
or AuNPs (top, blue). SESORS spectra of the mouse brain after the injection of 100 M
serotonin at a 0 mm offset (red) and a 1 mm offset (green) ........................................................126
Figure 6.1. SERS spectra of dopamine (blue), DOPAC (red), HVA (green), and 3-O-MD
(purple) in H2O (A), artificial urine (B), and aCSF (C) ...............................................................141
Figure 6.2. SEM images of Au modified electrodes ...................................................................144
Figure 6.3. SERS spectra of 50mM pyridine on AuNP modified carbon screen printed electrode
as the voltage was swept from +1.0 V to -2.0 V ..........................................................................146
Figure 6.4. SERS spectra of 10 M dopamine (A) and 10 M DOPAC on AuNP modified
carbon screen printed electrode as the voltage was swept from +1.0 V to -1.0 V .......................147
Figure 6.5.
carbon screen printed electrode as the voltage was swept from +1.0 V to -1.0 V .......................149

xiii

Abbreviations & Symbols
Polarizability
0

Polarizability at equilibrium position

aCSF

Artificial cerebral spinal fluid

ADU

Analog-to-digital converter units

AEF

Analytical enhancement factor

AgNPs

Silver nanoparticles

ATP

Adenosine triphosphate

AuNPs

Gold nanoparticles

c

Speed of light

CCD

Charge coupled device

CW

Continuous wave

d

Groove spacing

D

Diameter

DI

Deionized

DOPAC

3,4-dihydroxyphenylacetic acid

E

Electric field strength

E0

Laser amplitude

f

Focal length

f/#

F number

FON

Film over nanosphere

FSCV

Fast scan cyclic voltammetry

g

g-factor

GABA

-aminobutyric acid

xiv

HPLC

High performance liquid chromatography

HVA

Homovanillic acid

I0

Intensity of incoming flux

IRS

Intensity of Raman scattered light
Wavelength

LOD

Limit of detection

LSPR

Localized surface plasmon resonance

3-O-MD

3-O-Methyldopamine

MS

Mass spectrometry

n

Order of diffraction

P

Induced dipole moment

PCA

Principal component analysis

q

Nuclear displacement

q0

Vibrational amplitude

RS

Raman spectroscopy

SEM

Scanning electron microscopy

SERS

Surface enhanced Raman spectroscopy

SESORS

Surface enhanced spatially offset Raman spectroscopy

SORS

Spatially offset Raman spectroscopy

RS

t

Raman cross section
Time

d

Angle of diffraction

i

Angle of incidence

UV

Ultraviolet

xv

UPLC

Ultra-performance liquid chromatography

m

Frequency of the scattered radiation

0

Laser frequency
Frequency difference between incident and scattered radiation

s

Frequency of incident excitation

xvi

Chapter 1

General Introduction

1

The ability to monitor neurological function and changes is critical in early diagnosis of
neurological diseases, stress, or injury. Many neurological diseases are not diagnosed until a
substantial amount of neurological damage has already occurred, with the only confirmation of
the disease occurring after death through an autopsy.1-2 This late diagnosis leads to treatment
methods that are ineffective, often due to an early misdiagnosis of the disease. Many diagnostic
methods rely on the patient answering questions or body movements that evaluate their cognitive
motor functions, however, this requires that the patient be able to perform these tasks.1, 3 There is
a need for a method which looks at the underlying chemical changes in the development of
neurological disease through detection of biomarkers of the disease. A biomarker is a substance
that can be measured and which is characteristic of an infection or disease. Biomarker detection
can be used to provide point-of-care diagnosis for diseases that are difficult to detect including
neurological disease. A known diagnostic biomarker for neurological disease could lead to
earlier diagnosis and monitoring the progression of the disease. The purpose of this dissertation
is to develop a detection method for biomarkers of neurological disease, specifically
neurotransmitters. Monitoring fluctuations in neurotransmitter concentrations gives insight to the
condition of the brain.
The U.S. BRAIN Initiative sparked research in this area resulting in the emergence of
techniques investigating biomarkers of neurological disease.4 High performance liquid
chromatography (HPLC), ultra-performance liquid chromatography (UPLC), and mass
spectrometry (MS) are commonly used in the detection of neurotransmitters5-7, however, these
methods involve laborious and extensive sample preparation, complex and expensive
instrumentation and long collection times. Electrochemical detection methods are very sensitive
for use with detection of neurotransmitters8-9, however, these methods can be invasive involving
drilling holes in or cutting out portions of the skull to directly detect neurotransmitters in the
2

brain. Electrochemistry can also lack specificity when investigating neurotransmitters with very
similar oxidation potentials. Fluorescence methods have also been used for neurotransmitter
detection10-12 but also require extensive sample preparation and fluorescent labeling of the
sample. Imaging techniques can be used non-invasively, such as magnetic resonance imaging
(MRI) and functional MRI (fMRI), to give excellent spatial resolution, however, these
techniques give no chemical information.13 Raman spectroscopy has the ability to overcome
these limitations with the extreme selectivity to target molecules using simple instrumentation.14
When the vibrational modes of a molecule interact with a monochromatic light source, or

for each analyte. The Raman scattered light, however, is very weak. In order to achieve the
detection of low concentration analytes similar to what is present in the physiological
environment, surface enhanced Raman spectroscopy (SERS) is used. SERS results in an
enhanced Raman signal by adsorbing the analyte of interest to a metal nanoparticle. The
interaction of the metal nanoparticle with the laser drives the collective oscillation of the surface
conduction electrons, producing an enhanced electric field. When an analyte is within 1-2 nm of,
or adsorbed to the nanoparticle surface an enhanced Raman signal from the molecule is
observed.15-16
After the initial discovery of SERS there was considerable interest in the 1980s-1990s in
the SERS detection of neurotransmitters17-19, however, the interest quickly declined until the
commencement of the BRAIN Initiative in 20134. There are conflicting results in the literature of
the SERS detection of neurotransmitters where there is no comprehensive study of the detection
of multiple neurotransmitters known to be associated with neurological disease. The details of
SERS detection of neurotransmitters reported in the literature is elucidated in Chapter 3.

3

In order to develop a non-invasive method for the detection of neurotransmitters in the
body, SERS can be combined with spatially offset Raman spectroscopy (SORS) in a technique
termed SESORS. SORS allows detection of subsurface layers of turbid media through a surface
layer by taking advantage of the spatial component of light. The Raman light is collected at a
point that is spatially offset from the incident illumination point to collect the subsurface photons
that have migrated laterally before being scattered from the surface.20 All techniques are
discussed in detail in Chapter 2.
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Chapter 2

Raman Spectroscopy and Instrumentation

8

2.1 Raman Spectroscopy
2.1.1 Introduction
Raman spectroscopy is a vibrational spectroscopy that gives information about the
vibrational modes of a system through the interaction with a monochromatic light source, or a
laser.1 The Raman Effect was discovered in 1928 by Sir C. V. Raman while passing the violet
light of the solar spectrum through a liquid sample and observing that some of the scattered light
was a different color than the incident light. Due to the inherent weakness of Raman scattered
light, sunlight proved to be an inefficient excitation source. The development of the laser in 1960
stimulated an abundance of research applications using Raman spectroscopy.2 When
monochromatic light from a laser interacts with a molecule, the light is scattered from the
molecule both elastically and inelastically. Elastic scattering, also referred to as Rayleigh
scattering, describes the process where there is no interaction between the light and the molecule
and the light is scattered out at the same wavelength as the incident radiation. With inelastic
scattering, the light interacts with the molecule resulting in an energy shift of the scattered light
from the incident wavelength. This inelastic scattering is referred to as Raman scattering and
involves the absorption of energy by the photon or the loss of energy by the photon. The
absorption of energy by the photon from a vibrational mode results in anti-Stokes scattering,
where the light is scattered at a higher energy. When the energy is transferred from the photon to
the vibrational mode, the light is scattered back out at a lower energy and is referred to as Stokes
scattering. This energy shift is unique to the vibrational modes present in a molecule, which
3

9

2.1.2 Theory
An electromagnetic wave, or laser beam, has an electric field strength E which fluctuates
with time t. This is represented by equation 2.1 where E0 and

0

represent the vibrational

amplitude and frequency of the laser, respectively.
2.1
When a molecule is excited by a laser, or placed in an electric field, E, an induced electrical
dipole moment, P is experienced (equation 2.2).
2.2
In equation 2.2,

represents the polarizability of a molecule. The nuclear displacement q, of a

molecule vibrating with a frequency of

m

can be written as
2.3

where q0 is the vibrational amplitude (equation 2.3). We can then write equation 2.4 in which
is a linear function of q for a vibration with a small amplitude and
polarizability and the rate of change of

0

and (

/ q)0 is the

with respect to change in q, respectively, both

evaluated at the equilibrium position.
2.4

We can then combine equation 2.2 with equation 2.4 to obtain equation 2.5

2.5
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We can apply the trigonometric identity of

to yield

equation 2.6

2.6

where the first term represents Rayleigh scattering, the second term represents anti-Stokes
scattering, and the third term represents Stokes scattering. For a vibration to be Raman active,
there must be a change in polarizability, specifically (

/ q)0

0. If (

/ q)0 = 0, the vibration is

not Raman active.2-3
In normal Raman spectroscopy, the energy of the scattered photon does not correspond to
a difference between two energy levels of a molecule. The excitation occurs by a change in the
polarizability from the distortion of the electron cloud inducing a dipole. The energy is then

state (Figure 2.1). For anti-Stokes Raman scattering, the molecule must be in a higher energy
state (v=1), which can be induced by thermal excitation, where Stokes scattering can occur from
the ground state (v=0). The population of the molecules in the v=0 state is much higher than the
population of the v=1 state, explained by the Maxwell-Boltzmann distribution, resulting in much
more intensity from Stokes scattering versus anti-Stokes scattering. For this reason, the Stokes
Raman scattering is typically measured as opposed to the anti-Stokes scattering.3
For Raman spectroscopy, the intensity of scattered light is measured as a function of
wavelength when a monochromatic light source, or laser is focused onto a sample. A Raman
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spectrum has axes that represent the intensity of scattered light versus the Raman wavenumber.
The Raman wavenumber

denotes the difference in frequency between the incident

electromagnetic radiation and the scattered light (equation 2.7).
2.7

In equation 2.7,

m

is the frequency of the scattered radiation,

radiation, c is the speed of light and wavenumbers,

0

is the frequency of the incident

are typically expressed in cm-1. A typical

Raman spectrum of benzenethiol is shown in figure 2.2.
The intensity of the Stokes Raman scattered light IRS is proportional to the Raman cross
section

RS

and the incoming photon flux I0 (equation 2.8).4
2.8

The incoming photon flux is reported in units of photons s-1 cm-1 where the Stokes scattered light
is reported in units of photons s-1. The Raman cross section,

RS,

is significant of the available

area of a molecule for scattering. This cross section has units of cm2 and is dependent upon the
frequency of the incident excitation,
derivative

s

to the fourth power and the square of the polarizability

for a vibrational transition, shown in equation 2.9.4
2.9

For normal Raman spectroscopy, the approximate order of magnitude for a Raman cross section
of a molecule ranges from 10-30 cm2-10-26 cm2.4 The small Raman scattering cross sections
require a large number of molecules to be present (i.e. high concentrations of analyte) in order to
achieve a detectable Raman signal. While Raman spectroscopy provides excellent specificity, it
gives an inherently weak signal, only permitting detection of analytes in high concentrations.
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2.2 Surface Enhanced Raman Spectroscopy (SERS)
2.2.1 Introduction
Normal Raman spectroscopy does not allow detection of very low concentrations of
analyte similar to what is seen in the physiological environment. Based on equation 2.2,
increasing the electric field will enhance the Raman signal acquired and lead to decreased limits
of detection (LOD). One way to achieve an increased electric field is through surface enhanced
Raman spectroscopy (SERS). SERS was discovered in 1977 by Jeanmaire and Van Duyne5 who
theorized that the greatly enhanced signal from a monolayer of pyridine adsorbed on a roughened
silver electrode observed by Fleischman et al.6 was due to enhanced electric fields. During this
same time, Albrecht and Creighton7 proposed that the increased signal was due to a resonance
enhancement, where the excitation occurs within the molecular electronic states.
2.2.2 Mechanism of SERS
Generally, it is viewed that both electromagnetic and chemical interactions between the
analyte and substrate contribute to the enhanced signal obtained with SERS. Chemical
enhancement is said to be due to a resonant charge-transfer state between the analyte and
substrate. Electromagnetic enhancement is dependent on the roughness and dielectric properties
of the substrate and has been more thoroughly studied. The electromagnetic enhancement
dominates the SERS enhancement mechanism with it being responsible for 105-106 of the overall
SERS enhancement of 106-108, while the chemical enhancement only contributes factors of 10100.8
The enhanced electric field of SERS occurs through a phenomenon known as the
localized surface plasmon resonance of conductive metal nanoparticles (Figure 2.3).8-12 The
LSPR is the electric field produced through the collective oscillation of conduction band
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electrons of a metal nanoparticle when excited with a laser which increases the polarizability of
the surface and localized electric field. The increased SERS Raman cross section contributes to
the enhanced signal obtained where the SERS cross section for a molecule has an approximate
order of magnitude of 10-16 cm2. Various experiments have been conducted to determine the
experimental parameters that influence the LSPR of the nanoparticle and thus the enhancement
of SERS nanoparticles.8 The results show that the LSPR is dependent upon the size, shape,
roughness, and dielectric environment of the nanoparticle.
For particles that are smaller than the wavelength of incident illumination, all interactions
are characterized as surface interactions, where bulk properties are not observed. A simple model
for the LSPR is demonstrated for a single particle.13 The electrons travel freely throughout the
material and are influenced by an electromagnetic field. The incident electric field results in a
collective oscillation of the electrons only at particular frequencies that are within or close to
within the field frequency which results in a standing wave. This resonance field frequency is
what is dependent on the size, shape, and dielectric function of the particle. The method used to
measure these resonant excitations or LSPR of the nanoparticles is with extinction spectroscopy
(absorption + scattering).14
Theoretical calculations of extinction spectra have been performed for spherical
n.13, 15
Using the discrete dipole approximation (DDA), the LSPR can be numerically calculated for any
geometry where the particle is represented as N polarizable points in a cubic lattice and the
induced polarization of each point, Pi, is given by equation 2.10.
2.10
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In equation 2.10,

i

is the polarizability of the i th element which is centered at ri and Eloc(ri)

represents the sum of the incident electric field and all other dipoles in the particle at position i.
Thus, as the particle size increases, the LSPR is shifted to longer wavelengths.
The shapes and number of nanoparticles change the position and shape of the LSPR such
as a nanoparticle rod. When a rod forms, two LSPR peaks are observed in the extinction
spectrum, one for the longitudinal oscillation, and the other for the transverse. When the
nanoparticles aggregate, or when more than one particle approaches another to within a few
diameters, the LSPR is significantly redshifted and broadened.14 This represents a coupling of

The dependence of the LSPR on these factors demonstrates the ability to develop a tunable
substrate in order to optimize detection conditions.16
Calculations of the localized electric field at the surface begins with a simple model
system, consisting of a single metal spheroid which is small relative to the incident wavelength
of light and is coated with analyte molecules. The polarizability of the sphere is proportional to
the volume of the sphere and a g factor found through analytical solutions to M
equations. (Equation 2.11)

2.11

The electric field at the analyte, E( ), can be calculated at the incident frequency,

, and at the

frequency of Raman scattering,
factor that is proportional to [E( )]2[E(

2.
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The most common way to calculate enhancement factors for SERS is through the
analytical enhancement factor (AEF). The AEF gives the amount of signal that can be obtained
for a specific type of nanoparticle.17

2.12
In equation 2.12, d /d

is the differential Raman cross section and ta is the acquisition time.

Equation 2.13 can be used to find the differential Raman cross section.
2.13

IA represents the integrated area under a peak of interest in the normal Raman or SERS spectrum
and c is the concentration of the analyte. By substituting equation 2.13 into equation 2.12, we
obtain equation 2.14.18

2.14
2.2.3 Nanoparticle Synthesis
Materials commonly used for SERS substrates for excitation in the visible and near
infrared range are noble or coinage metals including silver (Ag), gold (Au), and copper (Cu).
These metals can be used to synthesize nanoparticles in a variety of shapes including but not
limited to spheres, rods, prisms, cubes, and nanoraspberries.13 SERS substrates can also be
synthesized in a 2-dimensional (2D) morphology which have proven to be more reproducible.
Two criteria must be met for the complex dielectric function of a metal for the nanoparticle to
exhibit plasmonic properties. The first is that the real component of the dielectric constant must
be large and negative and the second is that the imaginary component must be small and
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positive. For Ag, Au, and Cu, these conditions are met in the visible and NIR regions of the
electromagnetic spectrum, demonstrating their usefulness for SERS substrates in these regions.19
For the projects outlined in this dissertation, both Au and Ag nanoparticles (AuNPs,
AgNPs, respectively) have been synthesized in various morphologies and sizes. Citrate reduced
Au spherical colloids have been synthesized using well-established methods.20-21 First, the
methods established by Frens21 were used, who outlined procedures for making citrate reduced
AuNPs of varying sizes. For the purposes of our research, we have found that particles averaging
in size of 60-80 nm give the best SERS signal and are the most reproducible. To synthesize
particles of this size, a 0.01% by weight solution of HAuCl4 and a 1% by weight solution of Na3citrate are made. A volume of 45 mL of the HAuCl 4 solution is brought to a boil where 0.3 mL
of the Na3-citrate solution is added and boiled for an additional 5 minutes.
The methods established by B.V. Enüstün and J. Turkevich20 are a modified version of
the Frens synthesis and are used to synthesize larger volumes of citrate reduced AuNPs. We have
also used this method, where 850 mL of deionized H2O were boiled in a 1L flask. Once the
solution was boiling, 100mL of a 0.05% by weight solution of HAuCl4 was added. The resulting
solution was, again, brought to a boil where 50 mL of 1% by weight Na3-citrate was added. After
addition of the Na3-citrate, the solution was boiled and stirred continuously for 30 minutes. The
synthesized AuNPs were 60 nm on average with an LSPR max of 525 nm. (Figure 2.4)
Ag spherical colloids were prepared using two different reducing agents. The first
method was established by Lee and Miesel22 and involves a reduction of silver nitrate with
sodium citrate. Briefly, 90 mg of silver nitrate was dissolved in 500 mL of deionized H2O. This
solution was brought to a boil where 10 mL of 1% by weight Na3-citrate was added and
subsequently allowed to boil for 1 hour. The second method described by Creighton et al.23
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Figure 2.4: SEM image (A) and extinction spectrum (B) of AuNPs synthesized with the
methods established by Eüstün and Turkevich.
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involves a reduction of silver nitrate with sodium borohydride. Briefly, 1 mM sodium
borohydride was prepared and allowed to cool to 5 C and 2 mM silver nitrate was prepared at
room temperature. Under strong stirring, 3 volumes of the 1 mM sodium borohydride at 5 C was
added dropwise to 1 volume of the 2 mM silver nitrate and allowed to stir for 30 minutes.
Au nanoraspberries have also been synthesized according to methods established by
Masson24 which uses HEPES as a reducing agent. Nanoraspberries, which are a nanoparticle
with a raspberry-like configuration, are known to be more enhancing than spherical colloids. A
100mM solution of HEPES buffer, pH 7.4 and a 250 mM HAuCl4 solution were made. 6.25 mL
of HEPES buffer was added to 100 mL of deionized H2
HAuCl4 solution. The solution was allowed to stir overnight at room temperature.
2D substrates are known to give a more reproducible enhancement than colloidal
solutions.25 One type of these 2D substrates that has been used during this project is a Au film
over nanospheres (Au FONs). These substrates were synthesized by dropcasting polystyrene
spheres on glass coverslips followed by sputtering of a 200 nm layer of Au. The glass substrates
were cleaned in a piranha solution (3:1 H2SO4:H2O2) for 30 minutes then rinsed with copious
amounts of deionized H2O. The glass substrates were then sonicated for 1 hr in a 5:1:1 H 2O:
H2O2:NH4OH solution to make the surface hydrophilic which promotes self assembly of the
polystyrene nanospheres. The substrates were, again, rinsed with copious amounts of deionized
H2O and. Polystyrene beads (390 nm) were then drop-casted on the surface of the treated glass
substrates and allowed to dry in ambient conditions. A 200 nm layer of Au was then deposited
with an AJA Magnetron Sputtering System at a deposition rate of 2 Å/s.
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2.3 Spatially Offset Raman Spectroscopy (SORS)
2.3.1 Mechanism of SORS
A disadvantage of normal Raman spectroscopy when investigating materials with
multiple layers is the strong bias towards the surface layer. Probing the deeper layers of diffusely
scattering media can be achieved with spatially offset Raman spectroscopy (SORS). SORS is a
nondestructive, noninvasive technique that takes advantage of the spatial component of the
photon migration process through the collection of the Raman scattered light at a point that is
spatially offset from the incident illumination point. The technique was developed as a
subsurface detection technique following the use of ultrafast temporal gating. When photons
travel deeper into the subsurface layers of a material, the Raman scattered photons are
temporally separated from the Rayleigh scattered photons, i.e. the Raman signal decays more
slowly than Rayleigh signal. By gating the signal with ultrafast temporal gating, the Raman light
that has emerged from the deeper layers of the material can be selectively captured. Temporal
gating, however, requires the use of high intensity laser pulses leading to very complex and
costly instrumentation. Instead, by utilizing the spatial component of light, subsurface layers can
be probed using simple instrumentation and laser powers that remain within the safe exposure
limits.26
Photons that emerge from these subsurface layers travel longer distances to the surface
and diffuse laterally during this process resulting in the signal being in a larger spatial area than
the surface signal. (Figure 2.5) Collecting the Raman scattered light at a point that is laterally
offset from the incident illumination point, the signal from the deeper layers of a material can be
obtained. The size of the spatial offset used is dependent upon the thickness of the surface layer
of the sample and the desired detection depth. The contribution from the surface layer should
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Figure 2.5: Schematic of SORS describing the pathway of photons deep in the material before
scattering from the surface.
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decrease more rapidly than the contribution from the subsurface layer.26 The Raman spectra of
the subsurface layer in a two-layered material can be separated from the surface layer through a
scaled subtraction of the spectrum collected with no spatial offset from the spectrum collected
with a spatial offset. If a sample contains more than two layers, multivariate analysis techniques
can be utilized to separate the individual layers.27
SORS is excellent for applications with biological and organic materials as well as in vivo
applications where it has the ability to suppress the fluorescence associated with the surface
layers often involved in these types of samples.26 The technique is limited, however, in working
with metallic and highly absorbing samples where there is a reduction in the distance of photon
migration, resulting in a smaller depth of penetration.
2.3.2 Collection Geometry
Illumination of the sample and collection of Raman scattered light in SORS can be
accomplished in a number of geometries. The simplest collection geometry is a single point
collection, which permits any normal Raman set-up to be easily adapted to obtain SORS data. In
a point collection geometry, simple optics such as a dichroic mirror are used to move the
illumination point and achieve the spatial offset. (Figure 2.6A) The scattered light is
subsequently collected in a 180 backscattering geometry and directed into the spectrometer.
Although a point collection provides simplicity in the set-up, it results in a limited sensitivity.26
Fiber optic probes can be used in SORS for an increased sensitivity in two different
geometries. The first geometry, conventional SORS, involves the collection fibers being
arranged in a ring pattern where each ring represents a different spatial offset. The laser spot
illuminates the sample through a small spot centered in the rings. (Figure 2.6B) Conventional
SORS allows probing of biological tissue while maintaining safe illumination powers, however,
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spectral distortions arise from multiple Raman spectra being collected on different tracks of a
charge coupled device (CCD). This leads to decreased sensitivity where artefacts arise in the
spectra during post processing.26 The second geometry is referred to as inverse SORS and
switches the illumination and collection fibers. (Figure 2.6C) Inverse SORS allows for use of
overall higher laser powers where sample illumination occurs through a ring and the Raman
signal is collected through a group of fibers in the center. This permits the binning of the signal
onto the CCD in a single spectrum, eliminating artefacts apparent in processing with
conventional SORS.28 Inverse SORS can also be achieved through use of optics such as a conical
lens, or axicon where the size of the spatial offset is changed by modifying the distance between
the axicon and the sample.29
When the goal is to identify a known signal at an unknown location by investigating the
bulk of a sample, transmission Raman is most useful. Transmission Raman separates the
illumination and collection points to the extreme by illuminating on one side of the sample and
collecting the Raman scattered light through the other side of the sample. (Figure 2.6D) This
permits probing of the entire volume of a sample and is insensitive to the depth of the target
analyte.30 Conversely, when looking at very thin layers of turbid media, microscopy can be
combined with SORS. The spatial offset is achieved by defocusing the laser from the sample.
Initially, the spectrum should be taken with the laser focused on the sample, followed by a
spectrum with the laser defocused from the sample. A scaled subtraction can reveal the spectrum
of the subsurface layers (Figure 2.6E).31
In order to probe analytes in low concentrations in subsurface layers of diffusely
scattering media, SORS can be combined with SERS in a technique termed SESORS. To obtain
SESORS data, SERS active nanoparticles or a SERS nanotag are implemented into deep layers
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Figure 2.6: SORS geometries of a point collection (A), conventional SORS (B), inverse SORS
(C), transmission Raman (D), and micro-SORS (E).
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of turbid media followed by SORS measurements to reveal an enhanced signal of the subsurface
layers.32
2.4 Instrumentation
2.4.1 Introduction
There are four major components that make up a Raman optical system including the
excitation source, sample delivery and collection system, spectrograph, and detection and
computer system. There are commercially available Raman systems, or they can be home-built.
All of the experiments in this dissertation were conducted on home-built Raman systems.
2.4.2 Excitation Sources
Before the development of the laser, the primary excitation source used for Raman
spectroscopy was typically a mercury lamp. Filters were used in combination with the lamps in
order to select a single or small wavelength range. These lamps required a great amount of time
to warm up and ignite and were riddled with problems of shutting down intermittently. Lasers
are an ideal excitation source for Raman spectroscopy due to several factors; they have high
powers, narrow line widths, small beam diameters, are linearly polarized, and can be tunable.
The smaller, more focused diameters of lasers made it possible to decrease the sample volume
used as well as increase the power of the excitation source. Most of the early lasers were gas
lasers which emitted light in the visible region. Today, the lasers used are continuous wave (CW)
or pulsed. Pulsed lasers are typically used for nonlinear studies that require higher powers. CW
lasers are more commonly used and allow for a stable, constant illumination source at lower
powers. Materials used for the most commonly used Raman lasers are Argon, Krypton, Heliumneon (He-Ne), Titanium-Sapphire, yttrium aluminum garnet (YAG), and diode.2-3, 33
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For the purposes of this dissertation, in the visible and NIR range two diode lasers were
used at wavelengths of 532 nm and 785 nm as well as a He-Ne gas laser at 633 nm. Diode lasers
are advantageous due to their stability, low cost, small footprint, and reduced interference from
fluorescence background.34 He-Ne lasers were the first gas lasers demonstrated and have
historically been chosen for applications in the visible range of the electromagnetic spectrum. It
has better coherence and beam quality than that of diode lasers at similar wavelengths and is very
cost effective.35 In the UV range of the electromagnetic spectrum, a tunable kilohertz (kHz)
Ti:Sapphire laser (Photonics Industries). This tunable laser can be operated at wavelengths
ranging from 193 nm to 960 nm.
2.4.3 Sample Delivery and Collection System
As previously mentioned, Raman scattering is inherently weak, thus to obtain the most
intense signal, the laser must be tightly focused onto the sample. The subsequent scattered
radiation must also be collected efficiently. This can be controlled with optics, specifically
focusing and collecting lenses. The laser source can be directed toward the sample and aligned
using mirrors and a set of irises. A focusing lens should then be placed before the sample to
achieve a tight focus of the laser and an increased power density. To collect the light and direct it
into the spectrometer a set of collection lenses is used which include a collimating lens to collect
and direct the light onto a focusing lens which focuses the collected light into the slit of the
spectrometer. It is very important here to match the F number (f/#) of these collection lenses with
the f/# of the spectrometer to get maximum efficiency.3 The appropriate focal length for the
collection lenses can be calculated by using the lens equation
2.15
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where the f/# should match the f/# of the spectrometer, f is the focal length of the lens needed,
and D is the diameter of the lens. An adjustable sample stage should also be used that permits
movement of the sample to achieve maximum focus.
2.4.4 Spectrograph
A spectrograph is a dispersive instrument that is used to spatially disperse light so that a
detector can record the photons at different Raman shifts. Spectrographs consist of a dispersive
element such as a grating or prism and an image transfer system, which includes entrance and
exit slits, mirrors, and lenses. A diffraction grating is a plane or concave plate that is ruled with
closely spaced grooves, which disperse polychromatic light into its constituent wavelengths.
They provide a linear dispersion of wavelengths where the dispersion of the grating is
given by

2.16

i

the angle of incidence (measured from the normal) and

d

is

is the angle of diffraction (measured

from normal). The resolution of the spectrograph is ultimately determined by the resolution of
the grating, which is directly proportional to the number of grooves the grating contains.36
The most commonly used monochromator is the Czerny-Turner model monochromator
(Figure 2.7). This is the monochromator design used for the experiments of this dissertation. The
F number of a spectrometer is described by the focal length of the collimator mirror divided by
D, which represents the size of the grating. To maintain good resolution, D must be large and the
focal length must also be large where most monochromators have an F number between 5-10.3
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Figure 2.7: Schematic of a Czerny-Turner Monochromator with an entrance and exit slit,
directing and collimating mirrors, and a grating.
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2.4.5 Detectors
After the dispersion of light by the spectrometer, a detector is used to measure the
intensity of photons at specific wavelengths. Recently, CCDs have become more popular over
the traditionally used photomultiplier tubes or photodiodes. To determine the type of detector
which is most useful, quality is measured by the background noise, sensitivity, and frequency
range.3 While photomultipliers have a high sensitivity and low background noise, they do not
have a linear response over the full range of wavelengths needed for Raman spectroscopy and
lack the desired speed in recording measurements.3, 33 Photodiode detectors have the ability to
cover a range of wavelengths, however they deteriorate without uniformity over time due to their
sensitivity to high photon counts such as those seen with Raman spectroscopy. A CCD has the
ability to cover a range of wavelengths with low readout noise and high quantum efficiency. 3, 33
For the work in this dissertation, a CCD was used as the detector.
A CCD is a silicon wafer that has a geometrically regular array of photosensitive pixels
that capture and store information in the form of localized electrons that vary with incident light
intensity. This array of pixels is a 2D array also known as the focal plane array (FPA). The
horizontal location is related to wavelength, where the wavelength position is determined by a
calibration and the vertical axis related to intensity. The CCD technology is based on doped
semiconductors where impurities are intentionally introduced into an extremely pure material to
change its electrical properties. Typically, a CCD is made with a p-doped metal-oxide
semiconductor so that electrons are stored. The incoming photons strike the surface and an
electron-hole pair is created described by the photoelectric effect. The electrons are then
collected and counted and fed into an output amplifier to produce the image.37
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2.4.6 Raman Systems Built in the Sharma Lab
In the Sharma lab, Dr. Sharma and I have built 3 different Raman systems. The first of
these is a confocal micro-Raman system for use in the visible and NIR range. (Figure 2.8) The
system consists of excitation wavelengths at 532 nm, 633 nm, and 785 nm. The laser light is
directed toward the microscope using a set of mirrors. With Raman spectroscopy, it is imperative
that the laser light be perfectly aligned to achieve the optimal signal. This can be achieved by
using a set of irises, which are movable and close down to a pinhole, so the laser can be aligned
in the center of the pinholes. After the light is aligned with a set of irises, it is focused onto a set
of periscope optics which consists of a set of stacked mirrors and is used to raise the level of the
laser. The purpose of the periscope is to raise the level of the laser to reach the entrance of the
microscope. The light then enters the Nikon TIU inverted microscope and is focused onto the
sample through an objective. The Raman scattered light then travels back through the objective
and exits the microscope to pass through a focusing lens and a long pass filter before entering the
IsoPlane SCT 320 spectrometer (Princeton Instruments). The long pass filter allows all of the
Raman scattered light, at wavelengths longer than the excitation wavelength to pass through as a
method to filter out the Rayleigh light before entering the spectrometer. The light is then
dispersed onto the PIXIS 400 CCD camera (Princeton Instruments). Optics are all uncoated to
permit use at various wavelengths and have been purchased from ThorLabs. This system is
excellent for SERS measurements where the laser spot can be focused to micrometer size,
increasing the power density and allowing the use of ultra-low powers. The use of a microscope
is also imperative when analyzing biological samples to investigate only the spots of interest.
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Figure 2.8: Macroscopic Raman system built in the Sharma Lab.
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Another Raman system used in the Sharma Lab is a macroscopic Raman system. This
system consists of only one laser wavelength of 785 nm. This system is most useful when
examining samples too large for investigation with a microscope, SORS measurements, or
biological samples. Biological tissue exhibits less fluorescence at NIR wavelengths, thus using
an excitation wavelength of 785 nm allows more information to be acquired versus other visible
wavelengths. The laser is directed onto the sample using a dichroic mirror, which acts similar to
long pass filter. This dichroic mirror reflects the light at the excitation wavelength (785 nm) and
allows all of the longer wavelengths to pass through (Raman scattered light). The Raman
scattered light is then passed through a collimating lens to collimate the cone of scattered light,
then through a focusing lens and long pass filter before entering the slit. The Acton LS785
spectrometer and PIXIS 400 camera were both purchased from Princeton instruments. (Figure
2.9) To achieve the spatial offset needed for SORS measurements, an optical element called an
axicon is used. An axicon transforms the laser spot into a ring of illumination, where the radius
of the circle is the size of the spatial offset (Figure 2.10).
The last system that was built in the Sharma Lab is for use in the ultraviolet range of the
electromagnetic spectrum. This system consists of a tunable k-Hz Ti:Sapphire laser purchased
from Photonics Industries. This uses a pulsed pump laser at an original wavelength of 527 nm
which is subsequently passed through a series of harmonic crystals to be tuned to wavelengths
ranging from 193 nm to 960 nm. With the ability to operate from the deep-UV to the infrared,
this robust laser gives excellent functionality to the Sharma Lab. The use of harmonic crystals
produces a laser spot that is often in the shape of a horizontal or vertical line. Cylindrical lenses
can be used to convert a non-spherical laser spot to a sphere and have been implemented into the
UV system. (Figure 2.11) The light is directed through a set of irises for alignment and up
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Figure 2.9: Macroscopic Raman system built in the Sharma Lab.

36

Figure 2.10: Placement of the axicon into the optical set-up of the macroscopic Raman system to
create a spatial offset for SORS measurements.
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through a focusing lens to a prism, where the prism redirects the light onto the sample. (Figure
2.12) Raman scattered light is then collected through a collimating lens and focused into a prism
monochromator before entering the spectrometer (McPherson). (Figure 2.13)
A single long pass filter cannot be used for all of the possible wavelengths of the UV
system. In order to filter out the Rayleigh light and send the Raman scattered light into the
spectrometer to be dispersed, a prism monochromator can be used. This prism is on a turnable
stage, which disperses the Rayleigh and Raman scattered light so that it can be turned to simply
move the Rayleigh light off of the entrance slit of the spectrometer and only allow the Raman
scattered light to pass through. The Raman scattered light is then dispersed onto a PyLoN camera
purchased from Princeton instruments.
2.5 Spectral Analysis
Often with large datasets that contain more variables than can be easily labeled,
unsupervised multivariate analysis techniques can be applied to reveal relationships between
samples. For this dissertation, we have used principal components analysis (PCA) to reduce the
dimensionality of the acquired SERS and SESORS spectra of neurotransmitters and reveal
relationships between the samples. This has aided in determining limits of detection (LOD) for
each neurotransmitter. PCA is widely used to reduce the dimensionality of the dataset through an
orthogonal transformation. This decomposes the data into a series of principal components where
each principal component contains a spectral pattern, or loading, and a score that describes the
relationship between the sample and principal component. By plotting the scores of the different
principal components, one can demonstrate clustering of the sample into classes that explain
major trends, groups or patterns in the data set.38-39 The PCA has aided in the decomposition of
the complex spectra and helped reveal spectral patterns not easily discernible by eye.
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Figure 2.11: UV Laser purchased from photonics industries. Light is directed through a set of
cylindrical lenses to obtain a spherical laser spot and subsequently directed toward the sample
with a set of mirrors.
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Figure 2.12: UV optics used to direct the light onto the sample. Laser light is directed from the
laser (from the right) and up through a focusing lens and a prism to redirect the light onto the
sample. Raman light is then scattered back and a set of collection lenses are used to direct the
light into the spectrometer.
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Figure 2.13: Pathway of Raman scattered light into the spectrometer. The Raman scattered light
is collimated and sent through a focusing lens to enter the slit of the prism monochromator where
the Rayleigh light can be filtered and the Raman light is allowed to pass to the spectrometer
where it is dispersed onto the camera.
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Chapter 3

Multi-metal, multi-wavelength surface-enhanced Raman
spectroscopy detection of neurotransmitters

46

Chapter 3 is an adaption of a research article in ACS Chemical Neuroscience. Moody, A.S. and
Sharma, B., Multi-metal, Multi-wavelength Surface-Enhanced Raman Spectroscopy Detection of
Neurotransmitters. ACS Chem. Neurosci. 2018. 9, 1380-1387. The article describes the
characterization of optimal SERS detection parameters for seven neurotransmitters. The SERS
detection was optimized on both silver and gold nanoparticles at three excitation wavelengths.
3.1 Abstract
The development of a sensor for the rapid and sensitive detection of neurotransmitters
could provide a pathway for the diagnosis of neurological diseases, leading to the discovery of
more effective treatment methods. We investigate the use of surface enhanced Raman
spectroscopy (SERS) based sensors for the rapid detection of melatonin, serotonin, glutamate,
dopamine, GABA, norepinephrine, and epinephrine. Previous studies have demonstrated SERS
detection of neurotransmitters, however, there has been no comprehensive study on the effect of
the metal used as the SERS substrate or the excitation wavelength used for detection. Here, we
present the detection of seven neurotransmitters using both silver and gold nanoparticles at
excitation wavelengths of 532 nm, 633 nm, and 785 nm. Over the range of wavelengths
investigated, the SERS enhancement on the silver and gold nanoparticles varies, with an average
enhancement factor of 105-106. The maximum SERS enhancement occurs at an excitation
wavelength of 785 nm for the gold nanoparticles and at 633 nm for the silver nanoparticles.
3.2 Introduction
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3.3 Experimental Section
3.3.1 Materials and Reagents
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3.3.2 Preparation of silver and gold nanoparticles
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3.3.3 SERS Sample Preparation

3.3.4 Raman Spectroscopy
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3.4 Results and Discussion
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Figure 3.1: SEM images of AuNPs (A) and AgNPs (B) used for SERS detection.
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Chapter 4

Surface Enhanced Spatially Offset Raman Spectroscopy detection of
Neurochemicals Through the Skull

88

Chapter 4 is an adaption of a research letter in ACS Analytical Chemistry. Moody, A.S.,
Baghernejad, P. C., Webb, K. R., and Sharma, B., Surface Enhanced Spatially Offset Raman
Spectroscopy Detection of Neurochemicals Through the Skull. Anal. Chem. 2017, 89, 56885692. After characterization of the optimal detection parameters using SERS, we wanted to
apply this method in vivo. This article describes the detection of neurochemicals through an
animal skull in a brain mimic as a potential in vivo detection method for neurotransmitters that
would be minimally invasive.
4.1 Abstract
The ability to noninvasively detect neurotransmitters through the skull would aid in
understanding brain function and the development of neurological diseases. Surface enhanced
spatially offset Raman spectroscopy (SESORS) is a powerful technique that combines the
sensitivity of surface enhanced Raman spectroscopy (SERS) with the ability of spatially offset
Raman spectroscopy (SORS) to probe subsurface layers. Here we present SERS measurements
of neurotransmitters (melatonin, serotonin, and epinephrine) at various concentrations followed

brain tissue mimic through a cat skull. Principal components analysis was performed to
distinguish between the surface bone layer and the subsurface layer, comprised of a brain tissue
mimic modified with neurotransmitters, and to determine if each individual neurotransmitter
could be accurately identified.
4.2 Introduction
Optical cerebral imaging is a rapidly expanding field in need of new techniques for
gaining a greater understanding of brain function. Current noninvasive imaging techniques lack
the ability to measure local concentrations of neurotransmitters, which are typically measured
exogenously. Measurements of structural and functional information on neurochemicals have
89

been shown with techniques such as fast scan cyclic voltammetry (FSCV),

two-photon

microscopy,5 and optogenetics.6 All three techniques are invasive, with FSCV and optogenetics
involving drilling holes into the skull and two-photon microscopy requiring a craniotomy.
Recent advances in combining bioresponsive imaging agents with functional MRI (fMRI)
technology are now allowing for quantitative measurements to be made concurrent with
imaging.7 Knowledge of properties and local concentrations of neurochemicals is critical to
understanding neurological functions, fueling the need for a noninvasive procedure for
measuring neurochemicals in the brain.
We present a method utilizing Raman spectroscopy to noninvasively detect low
concentrations of neurotransmitters through the skull. Conventional Raman spectroscopy
provides superb chemical specificity with simple instrumentation but has a strong bias toward
surface layers and gives inherently weak signals. Our approach combines two types of Raman
spectroscopy, surface enhanced Raman spectroscopy (SERS) and spatially offset Raman
spectroscopy (SORS), to provide enhanced Raman signals from molecules in deep layers of
turbid media.
SERS provides a greatly enhanced Raman signal from low concentration analytes that have been
adsorbed to noble metal nanoparticles. The enhanced signal is a result of an intensified electric
field due to the excitation of the localized surface plasmon resonances (LSPR) of the metal
nanoparticles. Camden et al. have calculated Raman signal enhancements by factors up to
1010 1011.

8

SERS is surface selective and highly sensitive and has been applied in biological

disease.9
By collecting Raman spectra from a location at a set distance away from the incident
illumination point, the Raman signal can be obtained from subsurface layers. This technique,
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known as spatially offset Raman spectroscopy (SORS), is based on the concept that photons
which interact with subsurface layers have to travel larger distances where they diffuse laterally
through the material before scattering from the surface.10,11 SORS uses a continuous wave laser
beam which allows illumination with higher powers, while remaining within maximum exposure
limits. This method was initially described by Matousek et al. using a diffusely scattering, twolayer sample of trans-stilbene powder beneath a 1 mm thick layer of PMMA.12 It has since been
demonstrated in applications such as the noninvasive Raman spectroscopy of bones of animal
and human samples by Morris et al.,13 in vivo observation of human tissue by Matousek et al.,14
and detecting contributions of breast tumors buried in breast tissue by Keller et al.15
The combined surface enhanced SORS, termed as SESORS, has been demonstrated for in
vivo glucose sensing16,17 and for the measurements of nanoparticles embedded in tissue through
ovine bone.18 Here we present SESORS measurements of neurotransmitters embedded in a brain
tissue mimic through a cat skull.
4.3 Results and Discussion
Early experiments involved collection of SERS spectra of neurotransmitters, specifically
melatonin (Figure 4.1A), epinephrine (Figure 4.1B), and serotonin (Figure 4.1C) on Au
nanoparticles with enhancement factors of

105 in aqueous solution. The spectra were obtained

at various concentrations where representative peaks for each neurotransmitter can be identified
down to nanomolar concentrations. Spectra were collected using a 785 nm spectrum stabilized
laser (Innovative Photonic Solutions) with an average laser beam power at the sample of 50 mW.
The light was directed onto the sample using a dichroic mirror, which was also utilized to
achieve a spatial offset. The Raman light was then collected in an 180° backscattering geometry
and directed into the spectrometer (Acton LS 785, Princeton Instruments) where it was dispersed
onto a CCD detector (Pixis 400, Princeton Instruments).
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We measured the optical properties of four animal skulls, including diffuse reflectance
and transmittance measurements (Figure 4.2). In accordance with previous measurements of the
skulls of both adult pigs19 and human cadavers,20 our results show the skull is partially
transparent at a wavelength of 785 nm. This is significant because it indicates that we should be
able to both send 785 nm light through the skull as well as detect the light that is scattered back.
To mimic brain tissue, we used a 0.6% agarose gel. Studies on the properties of agarose gel show
that the poroelasticity and structure of the brain is analogous to that of a low concentration
agarose gel. The agarose gel has a web-like structure formed by cross-linking as fibers
overlap.21,22

First, we acquired a SERS spectrum of the benzenethiol adsorbed to the Au nanoparticles
in the gel. A fragment of a cat skull was then placed in front of the gel to acquire a spectrum with
no spatial offset followed by a spectrum at a spatial offset of 2 mm, which we previously
determined to be the optimal offset position for the thickness of the cat skull fragment (Figure
4.3). All raw spectra were processed using GRAMS software (Thermo Fisher Scientific). Each
spectrum was baseline corrected, since there is a visible fluorescence contribution in the
uncorrected spectra involving the skull. Finally, the zero mm offset spectrum was subtracted
from the 2 mm offset spectrum. The zero mm offset spectra (Figures 4.3 and 4.4) are dominated
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To confirm that our SESORS method can distinguish between the surface and subsurface
layers and clearly identify individual neurotransmitters we applied multivariate analysis to the
spectra. Specifically, principal components analysis (PCA) was performed. PCA identifies
relationships between samples and reduces dimensionality of the data set through an orthogonal
transformation to decompose the spectra into a series of principal components. Each principal
component encompasses a spectral pattern, or loading, and a score describing the correlation
between the sample and principal component. A plot of the scores of different principal
components shows clustering of samples into similar or dissimilar classes and explains major
trends in a data set.28 Multivariate analysis techniques are often performed to determine spectral
similarities and differences in Raman methods analyzing biological samples.28-31
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inability to detect the neurotransmitters without the use of SORS. We then applied the PCA
model to the difference spectra (2 mm offset minus 0 mm offset). Plotting PC4 versus PC5 gives
a separation of the neurotransmitters at different concentrations (Figure 4.6) into distinct areas of
the PCA plot. The spread between different concentrations of each neurotransmitter varies and
could be improved by increasing the number of data points in the PCA plot. Additionally, the
loading for PC4 shows a residual peak from broadening of the bone phosphate vibration due to
underlying neurotransmitter peaks.
4.4 Conclusion
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Chapter 5

In vivo Detection of Neurochemicals in a Mouse Brain Through the
Skull with Surface-Enhanced Spatially Offset Raman Spectroscopy

107

Chapter 5 is an adaption of a research article in preparation for submission to ACS Nano by
Moody, A.S., Payne, T. D., Barth, B. A., and Sharma, B. entitled

In vivo detection of

neurochemicals in a mouse brain through the skull with surface-enhanced spatially offset Raman
spectroscopy . This article describes the applicability of SESORS as a potential in vivo detection
method with the detection of serotonin in a mouse model. The detection of mixtures of
neurotransmitters was also achieved

and

LODs

were obtained for five different

neurotransmitters.
5.1 Abstract
Detection techniques for neurotransmitters that are rapid, label-free, and non-invasive are
needed to move towards earlier diagnosis of neurological disease. Surface-enhanced Raman
spectroscopy (SERS) allows for sensitive and selective detection of target analytes. The
combination of SERS with spatially offset Raman spectroscopy (SORS) in a technique termed
surface enhanced spatially offset Raman spectroscopy (SESORS) permits a sensitive and
selective detection of neurotransmitters through the skull. Here, we demonstrate the potential of
SESORS for an in vivo detection method by demonstrating the detection of 100 M serotonin in
the brain of a mouse model. We also present the SESORS detection of individual
neurotransmitters and mixtures of neurotransmitters, while establishing limits of detection.
5.2 Introduction

-

108

-

-

-

-

-

-

-

-

-

109

-

- -

5.3 Experimental Section
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5.3.2 Nanoparticle Synthesis

5.3.3 Preparation of Agarose Gels for SESORS Measurements

5.3.4 Raman Spectroscopy, SERS, & SESORS
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5.3.5 Dark Field Imaging
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Table 5.1 Peak positions associated with specified vibrational modes as well as the chemical
structures of serotonin and melatonin.
-

-
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Since Raman spectra are indicative of the vibrational modes of a molecule, mixtures of
neurotransmitters with a very similar structure will have spectra that are almost identical, with
some peak broadening, which arises due to slight shifts in peak positions from the small
structural differences in the molecules. There will also be a few Raman peaks that are unique to a
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To demonstrate the feasibility of SESORS as an in vivo method for animal models, we
collected SESORS spectra posthumously of exogenously injected serotonin in the brain of a
mouse model. The mouse skull is approximately 0.5-0.8 mm thick with a layer of skin covering
it at a thickness of 1 mm. We shaved the head of the mouse to remove light scattering effects due
to the hair. Prior to injecting the brain with serotonin and nanoparticles, we collected SORS
spectra at a 0 mm offset of the brain through the skull (Figure 5.6, blue trace). The spectrum
shows the prominent bone phosphate vibration at 960 cm-1. Additionally, we see broadened
peaks that arise from degrading brain tissue at 1072 cm-1 (

CC),

1445 cm-1 (

CH),

1661 (

CO, NH).
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Figure 5.5. SESORS spectra of mixtures containing melatonin and serotonin (A), dopamine,
epinephrine and norepinephrine (B), and dopamine, GABA, and DOPAC (C). The top spectrum
for each panel represents the contribution from the bone with no spatial offset (blue). The red
spectrum is the SESORS spectrum of the neurotransmitters in the agarose gel behind the rat skull
with a 2 mm spatial offset. The green spectrum shows a subtraction of the bone spectrum with no
spatial offset from the SESORS spectrum with a 2 mm offset revealing a pure spectrum of the
neurotransmitter. A SERS spectrum of the neurotransmitters and AuNPs embedded in the
agarose gel is displayed in purple.

ex=785

nm, P=90 mW, t=120 sec.
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5.5 Conclusion
We have presented the use of SESORS for a minimally invasive detection method for
neurotransmitters through the skull. AuNPs are an excellent choice for a potential in vivo
detection method due to their exceptional stability and low toxicity. Previous studies show the
best enhancement for the AuNPs at an excitation wavelength of 785 nm, which also mitigates
interferences from fluorescence resulting from the biological material. These AuNPs also

allow the detection of the aromatic neurotransmitters commonly known to be associated with
neurological diseases. We investigated the dispersion of the AuNPs in a brain mimic where the
results show an even distribution of AuNPs throughout the agarose gel. Neurotransmitters and
AuNPs were then embedded in agarose gel to find LODs for serotonin, norepinephrine,
melatonin, epinephrine, and dopamine through a rat skull. SESORS measurements were also
acquired for mixtures of neurotransmitters including neurotransmitters that are very similar in
chemical structure and those present in the substantia nigra
disease. The thickness of the skull in this area of the brain is approximately 3 mm thick, where
our technique shows great potential for an in vivo method. To further demonstrate the potential
of SESORS for an in vivo detection method, serotonin was detected in the brain of a mouse
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model at a concentration of 100 M. Detection of individual neurotransmitters is not a trivial
task. Future work will include the use of capture molecules including aptamers and antibodies to
increase the specificity of the nanoparticle SERS sensor and allow capture of a target analyte.
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Chapter 6

Electrochemical Surface-Enhanced Raman Spectroscopy for the
Selective Identification of Dopamine and Metabolites
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Chapter 6 is an adaption of a research article submitted to the Journal of the American Chemical
Society by Moody, A.S. and Sharma, B. entitled

-Enhanced Raman

Spectroscopy for the Selective Identification of Dopamine and Metaboli

. This article

describes the combination of two commonly used sensing techniques for neurotransmitters,
SERS and electrochemistry to selectively identify dopamine and DOPAC in a mixture, a
common limitation of electrochemistry. The paper also describes the SERS detection of
dopamine and its metabolites in aqueous solution, artificial urine, and artificial CSF.
6.1 Abstract
Early disease diagnosis is imperative during the development of neurological diseases,
would be most effective. This requires the use of
detection techniques that are sensitive and selective to identify the neurochemicals, which are
often similar in chemical structure. Surface-enhanced Raman spectroscopy (SERS) allows for
this selective detection, and when combined with electrochemistry permits the sensitive and
selective localized detection of analytes with similar oxidation potentials. We present here the
ine, 3,4dihydroxyphenylacetic acid, homovanillic acid, and 3-O-methyldopamine. A carbon screenprinted electrode modified with gold nanoparticles served as the SERS-active substrate during
the simultaneous electrochemical detection of dopamine and DOPAC. We demonstrate that the
combination of electrochemistry and SERS allows for highly sensitive and selective
identification of dopamine and DOPAC in a mixture.
6.2 Introduction

134

-

-

-

-

-

135

-

-

-

-

136

-

- - -

-

-

-

6.3 Experimental Section
6.3.1 Reagents and Materials

- -

--

-

6.3.2 Preparation of AuNPs

137

6.3.3 Preparation of SERS-Active Electrodes
-

-

-

6.3.4 SERS Measurements

-

138

6.3.5 Spectroelectrochemical Measurements
-

-

-

-

-

6.4 Results and Discussion

-

- -

- -

139

- -

140

- -

141

- -

-

-

- -

-

-

-

- -

-

-

-

-

142

Table 6.2: Normal brain concentrations as well as limits of detection for dopamine, DOPAC,
HVA, and 3-O-MD in H2O, artificial urine, and aCSF.
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Figure 6.5.
carbon screen printed electrode (A) as the voltage was swept from +1.0 V to -1.0 V with the
maximum intensity SERS spectra for both dopamine (blue) and DOPAC (red) extracted (B).
ex=785

nm, P=40 mW, t=30s.

149

6.6 Acknowledgements
This work was supported by the University of Tennessee (start-up funds). The authors
would like to acknowledge the University of Tennessee JIAM Microscopy Center for instrument
use, scientific, and technical assistance.

150

6.7 References
1.

Miller, D. B.; O'Callaghan, J. P., Biomarkers of Parkinson's Disease: Present and Future.

Metabolism 2015, 64, S40-S46.
2.

Olanow, C. W.; Tatton, W. G., Etiology and Pathogenesis of Parkinson's Disease. Annual

Review of Neuroscience 1999, 22, 123-144.
3.

Ferrer, I.; Lopez-Gonzalez, I.; Carmona, M.; Dalfo, E.; Pu-jol, A.; Martinez, A.,

Neurochemistry and the Non-Motor Aspects of Pd. Neurobiol Dis 2012, 46, 508-526.
4.

Riederer, P.; Wuketich, S., Time Course of Nigrostriatal Degeneration in Parkinsons-

Disease - Detailed Study of Influential Factors in Human-Brain Amine Analysis. J Neural
Transm 1976, 38, 277-301.
5.

An, J. H.; Choi, D. K.; Lee, K. J.; Choi, J. W., Surface-Enhanced Raman Spectroscopy

Detection of Dopamine by DNA Targeting Amplification Assay in Parkisons's Model. Biosens
Bioe-lectron 2015, 67, 739-746.
6.

Bisaglia, M.; Greggio, E.; Maric, D.; Miller, D. W.; Cook-son, M. R.; Bubacco, L.,

Alpha-Synuclein Overexpression Increases Dopamine Toxicity in Be(2)-M17 Cells. BMC
neuroscience 2010, 11.
7.

Bisaglia, M.; Mammi, S.; Bubacco, L., Kinetic and Struc-tural Analysis of the Early

Oxidation Products of Dopamine - Analy-sis of the Interactions with Alpha-Synuclein. Journal
of Biological Chemistry 2007, 282, 15597-15605.
8.

Bisaglia, M.; Soriano, M. E.; Arduini, I.; Mammi, S.; Bu-bacco, L., Molecular

Characterization of Dopamine-Derived Qui-nones Reactivity toward Nadh and Glutathione:
Implications for Mi-tochondrial Dysfunction in Parkinson Disease. Bba-Mol Basis Dis 2010,
1802, 699-706.

151

9.

Bisaglia, M.; Tosatto, L.; Munari, F.; Tessari, I.; de Laure-to, P. P.; Mammi, S.; Bubacco,

L., Dopamine Quinones Interact with a-Synuclein to Form Unstructured Adducts. Biochemical
and bio-physical research communications 2010, 394, 424-428.
10.

Briceno, A.; Munoz, P.; Brito, P.; Huenchuguala, S.; Se-gura-Aguilar, J.; Paris, I. B.,

Aminochrome Toxicity Is Mediated by Inhibition of Microtubules Polymerization through the
Formation of Adducts with Tubulin. Neurotox Res 2016, 29, 381-393.
11.

Cheer, J. F.; Wassum, K. M.; Sombers, L. A.; Heien, M. L. A. V.; Ariansen, J. L.;

Aragona, B. J.; Phillips, P. E. M.; Wightman, R. M., Phasic Dopamine Release Evoked by
Abused Substances Re-quires Cannabinoid Receptor Activation. J Neurosci 2007, 27, 791-795.
12.

Elsworth, J. D.; Roth, R. H., Dopamine Synthesis, Uptake, Metabolism, and Receptors:

Relevance to Gene Therapy of Parkin-son's Disease. Exp Neurol 1997, 144, 4-9.
13.

Gu, H.; Varner, E. L.; Groskreutz, S. R.; Michael, A. C.; Weber, S. G., In Vivo

Monitoring of Dopamine by Microdialysis with 1 Min Temporal Resolution Using Online
Capillary Liquid Chroma-tography with Electrochemical Detection. Anal Chem 2015, 87, 60886094.
14.

Hashemi, P.; Wightman, R. M., Paying Attention with the Latest Technology. Neuron

2007, 56, 4-5.
15.

Jackowska, K.; Krysinski, P., New Trends in the Electro-chemical Sensing of Dopamine.

Analytical and bioanalytical chemis-try 2013, 405, 3753-3771.
16.

Jentsch, J. D.; Redmond, D. E.; Elsworth, J. D.; Taylor, J. R.; Youngren, K. D.; Roth, R.

H., Enduring Cognitive Deficits and Cortical Dopamine Dysfunction in Monkeys after LongTerm Admin-istration of Phencyclidine. Science 1997, 277, 953-955.

152

17.

Johnson, M. A.; Villanueva, M.; Haynes, C. L.; Seipel, A. T.; Buhler, L. A.; Wightman,

R. M., Catecholamine Exocytosis Is Diminished in R6/2 Huntington's Disease Model Mice. J
Neurochem 2007, 103, 2102-2110.
18.

Kita, J. M.; Parker, L. E.; Phillips, P. E. M.; Garris, P. A.; Wightman, R. M., Paradoxical

Modulation of Short-Term Facilitation of Dopamine Release by Dopamine Autoreceptors. J
Neurochem 2007, 102, 1115-1124.
19.

Lidow, M. S.; Elsworth, J. D.; GoldmanRakic, P. S., Down-Regulation of the D1 and D5

Dopamine Receptors in the Pri-mate Prefrontal Cortex by Chronic Treatment with Antipsychotic
Drugs. J Pharmacol Exp Ther 1997, 281, 597-603.
20.

Robinson, D. L.; Wightman, R. M., Rapid Dopamine Re-lease in Freely Moving Rats.

Front Neuroeng 2007, 1, 17-34.
21.

Rojas, P.; Cerutis, D. R.; Happe, H. K.; Murrin, L. C.; Hao, R.; Pfeiffer, R. F.; Ebadi, M.,

6-Hydroxydopamine-Mediated Induc-tion of Rat Brain Metallothionein I Mrna. Neurotoxicology
1996, 17, 323-334.
22.

Touchette, J. C.; Breckenridge, J. M.; Wilken, G. H.; Mac-arthur, H., Direct Intranigral

Injection of Dopaminochrome Causes Degeneration of Dopamine Neurons. Neurosci Lett 2016,
612, 178-184.
23.

Van Laar, V. S.; Mishizen, A. J.; Cascio, M.; Hastings, T. G., Proteomic Identification of

Dopamine-Conjugated Proteins from Isolated Rat Brain Mitochondria and Sh-Sy5y Cells.
Neurobiol Dis 2009, 34, 487-500.
24.

Wang, N.; Wang, Y.; Yu, G. H.; Yuan, C. G.; Ma, J. Y., Quinoprotein Adducts

Accumulate in the Substantia Nigra of Aged Rats and Correlate with Dopamine-Induced
Toxicity in Sh-Sy5y Cells. Neurochemical research 2011, 36, 2169-2175.

153

25.

Wightman, R. M.; Heien, M. L. A. V.; Wassum, K. M.; Sombers, L. A.; Aragona, B. J.;

Khan, A. S.; Ariansen, J. L.; Cheer, J. F.; Phillips, P. E. M.; Carelli, R. M., Dopamine Release Is
Heteroge-neous within Microenvironments of the Rat Nucleus Accumbens. Eur J Neurosci
2007, 26, 2046-2054.
26.

Zachek, M. K.; Takmakov, P.; Park, J.; Wightman, R. M.; McCarty, G. S., Simultaneous

Monitoring of Dopamine Concentra-tion at Spatially Different Brain Locations in Vivo. Biosens
Bioelec-tron 2010, 25, 1179-1185.
27.

Lewitt, P. A.; Galloway, M. P.; Matson, W.; Milbury, P.; Mcdermott, M.; Srivastava, D.

K.; Oakes, D., Markers of Dopamine Metabolism in Parkinsons-Disease. Neurology 1992, 42,
2111-2117.
28.

Muzzi, C.; Bertocci, E.; Terzuoli, L.; Porcelli, B.; Ciari, I.; Pagani, R.; Guerranti, R.,

Simultaneous Determination of Serum Con-centrations of Levodopa, Dopamine, 3-OMethyldopa and Alpha-Methyldopa by Hplc. Biomed Pharmacother 2008, 62, 253-258.
29.

Farjami, E.; Campos, R.; Ferapontova, E. E., Effect of the DNA End of Tethering to

Electrodes on Electron Transfer in Meth-ylene Blue-Labeled DNA Duplexes. Langmuir 2012,
28, 16218-16226.
30.

Farjami, E.; Campos, R.; Nielsen, J. S.; Gothelf, K. V.; Kjems, J.; Ferapontova, E. E.,

Rna Aptamer-Based Electrochemical Biosensor for Selective and Label-Free Analysis of
Dopamine. Anal Chem 2013, 85, 121-128.
31.

Huang, J. S.; Liu, Y.; Hou, H. Q.; You, T. Y., Simultane-ous Electrochemical

Determination of Dopamine, Uric Acid and Ascorbic Acid Using Palladium NanoparticleLoaded Carbon Nano-fibers Modified Electrode. Biosens Bioelectron 2008, 24, 632-637.

154

32.

Lin, L.; Yang, J.; Lin, R. P.; Yu, L.; Gao, H. C.; Yang, S. L.; Li, X. K., In Vivo Study on

the Monoamine Neurotransmitters and Their Metabolites Change in the Striatum of Parkinsonian
Rats by Liquid Chromatography with an Acetylene Black Nanoparticles Mod-ified Electrode. J
Pharmaceut Biomed 2013, 72, 74-79.
33.

Wen, J. X.; Zhou, L.; Jin, L. T.; Cao, X. N.; Ye, B. C., Overoxidized Polypyrrole/Multi-

Walled Carbon Nanotubes Compo-site Modified Electrode for in Vivo Liquid ChromatographyElectrochemical Detection of Dopamine. Journal of Chromatography B-Analytical Technologies
in the Biomedical and Life Sciences 2009, 877, 1793-1798.
34.

Kovac, A.; Somikova, Z.; Zilka, N.; Novak, M., Liquid Chromatography-Tandem Mass

Spectrometry Method for Determina-tion of Panel of Neurotransmitters in Cerebrospinal Fluid
from the Rat Model for Tauopathy. Talanta 2014, 119, 284-290.
35.

Qin, L. X.; Li, X. Q.; Kang, S. Z.; Mu, J., Gold Nanoparti-cles Conjugated Dopamine as

Sensing Platform for Sers Detection. Colloid Surface B 2015, 126, 210-216.
36.

Ranc, V.; Markova, Z.; Hajduch, M.; Prucek, R.; Kvitek, L.; Kaslik, J.; Safarova, K.;

Zboril, R., Magnetically Assisted Surface-Enhanced Raman Scattering Selective Determination
of Dopamine in an Artificial Cerebrospinal Fluid and a Mouse Striatum Using Fe3o4/Ag
Nanocomposite. Anal Chem 2014, 86, 2939-2946.
37.

Tang, L. J.; Li, S.; Han, F.; Liu, L. Q.; Xu, L. G.; Ma, W.; Kuang, H.; Li, A. K.; Wang, L.

B.; Xu, C. L., Sers-Active Au@Ag Nanorod Dimers for Ultrasensitive Dopamine Detection.
Biosens Bioelectron 2015, 71, 7-12.
38.

Dieringer, J. A.; McFarland, A. D.; Shah, N. C.; Stuart, D. A.; Whitney, A. V.; Yonzon,

C. R.; Young, M. A.; Zhang, X. Y.; Van Duyne, R. P., Surface Enhanced Raman Spectroscopy:
New Materi-als, Concepts, Characterization Tools, and Applications. Faraday Discuss 2006,
132, 9-26.

155

39.

Masango, S. S.; Hackler, R. A.; Large, N.; Henry, A. I.; McAnally, M. O.; Schatz, G. C.;

Stair, P. C.; Van Duyne, R. P., High-Resolution Distance Dependence Study of SurfaceEnhanced Raman Scattering Enabled by Atomic Layer Deposition. Nano Lett 2016, 16, 42514259.
40.

Keithley, R. B.; Takmakov, P.; Bucher, E. S.; Belle, A. M.; Owesson-White, C. A.; Park,

J.; Wightman, R. M., Higher Sensitivity Dopamine Measurements with Faster-Scan Cyclic
Voltammetry. Anal Chem 2011, 83, 3563-3571.
41.

Kim, Y. R.; Bong, S.; Kang, Y. J.; Yang, Y.; Mahajan, R. K.; Kim, J. S.; Kim, H.,

Electrochemical Detection of Dopamine in the Presence of Ascorbic Acid Using Graphene
Modified Electrodes. Biosens Bioelectron 2010, 25, 2366-2369.
42.

Song, P.; Guo, X. Y.; Pan, Y. C.; Wen, Y.; Zhang, Z. R.; Yang, H. F., Sers and in Situ

Sers Spectroelectrochemical Investiga-tions of Serotonin Monolayers at a Silver Electrode. J
Electroanal Chem 2013, 688, 384-391.
43.

Zhang, L. J.; Wen, Y.; Pan, Y. C.; Yang, H. F., 2-Amino-5-(4-Pyridinyl)-1,3,4-

Thiadiazole Film at the Silver Surface: Observa-tion by Raman Spectroscopy and
Electrochemical Methods. Appl Surf Sci 2011, 257, 6347-6352.
44.

Abdelsalam, M. E.; Bartlett, P. N.; Baumberg, J. J.; Cintra, S.; Kelf, T. A.; Russell, A. E.,

Electrochemical Sers at a Structured Gold Surface. Electrochem Commun 2005, 7, 740-744.
45.

Cortes, E.; Etchegoin, P. G.; Le Ru, E. C.; Fainstein, A.; Vela, M. E.; Salvarezza, R. C.,

Electrochemical Modulation for Sig-nal Discrimination in Surface Enhanced Raman Scattering
(Sers). Anal Chem 2010, 82, 6919-6925.

156

46.

Zaleski, S.; Clark, K. A.; Smith, M. M.; Eilert, J. Y.; Doty, M.; Van Duyne, R. P.,

Identification and Quantification of Intrave-nous Therapy Drugs Using Normal Raman
Spectroscopy and Electro-chemical Surface Enhanced Raman Spectroscopy. Anal Chem 2017,
89, 2497-2504.
47.

Zhang, X. Y.; Yonzon, C. R.; Van Duyne, R. P., An Elec-trochemical Surface-Enhanced

Raman Spectroscopy Approach to Anthrax Detection. Plasmonics: Metallic Nanostructures and
Their Optical Properties 2003, 5221, 82-91.
48.

Robinson, A. M.; Harroun, S. G.; Bergman, J.; Brosseau, C. L., Portable Electrochemical

Surface-Enhanced Raman Spectros-copy System for Routine Spectroelectrochemical Analysis.
Anal Chem 2012, 84, 1760-1764.
49.

Frens, G., Controlled Nucleation for Regulation of Particle-Size in Monodisperse Gold

Suspensions. Nature-Phys Sci 1973, 241, 20-22.
50.

Pierce, R. C.; Rebec, G. V., Dopamine-Receptor, Nmda-Receptor and Sigma-Receptor

Antagonists Exert Differential-Effects on Basal and Amphetamine-Induced Changes in
Neostriatal Ascor-bate and Dopac in Awake, Behaving Rats. Brain Res 1992, 579, 59-66.
51.

Scheepers, F. E.; Wied, C. C. G.; Westenberg, H. G. M.; Kahn, R. S., The Effect of

Olanzapine Treatment on Monoamine Metabolite Concentrations in the Cerebrospinal Fluid of
Schizophren-ic Patients. Neuropsychopharmacol 2001, 25, 468-475.
52.

Mannisto, P. T.; Tuomainen, P.; Tuominen, R. K., Differ-ent Invivo Properties of 3 New

Inhibitors of Catechol O-Methyltransferase in the Rat. Brit J Pharmacol 1992, 105, 569-574.
53.

Tohgi, H.; Abe, T.; Takahashi, S.; Nozaki, Y.; Kikuchi, T., Concentrations of Tyrosine,

L-Dihydroxyphenylalanine, Dopamine, and 3-O-Methyldopa in the Cerebrospinal-Fluid of
Parkinsons-Disease. Neurosci Lett 1991, 127, 212-214.

157

54.

Gonon, F.; Buda, M.; Cespuglio, R.; Jouvet, M.; Pujol, J. F., Invivo Electrochemical

Detection of Catechols in the Neostriatum of Anesthetized Rats - Dopamine or Dopac. Nature
1980, 286, 902-904.

158

Chapter 7

Conclusion and Future Directions
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Raman spectroscopy, specifically SERS and SORS show excellent potential as a
detection method for neurochemicals to monitor and diagnose neurological disease. Initial SERS
investigations have been conducted which involve the optimization of SERS substrates and
excitation wavelength for the detection of seven neurotransmitters. Commonly used SERS
substrates for excitation wavelengths in the visible and NIR wavelength range are silver and gold
nanoparticles. Results show that for silver nanoparticles, the most intense Raman signal is
obtained at an excitation wavelength of 633 nm and an excitation wavelength of 785 nm gives
the most intensity for gold nanoparticles. These SERS substrates were also used for the detection
of the neurochemicals in biological fluids using gold nanoparticles at the optimal wavelength of
785 nm.
To extend this SERS detection method for a non-invasive detection of neurochemicals
through the skull, SESORS was used. Proof of concept experiments show that melatonin,
serotonin, and epinephrine could be detected in a brain mimic through a cat skull at
concentrations of 50 mM and 100 M. Subsequent investigations involved finding LODs for 5
neurotransmitters including melatonin, serotonin, epinephrine, norepinephrine, and dopamine
where all LODs were in the M-nM concentration range. The AuNPs in the brain mimic were
also shown to be evenly dispersed with dark field imaging. A maximum detection depth was also
found to be 18 mm through a rat skull with 2 mm thickness. This method was shown to be
suitable for an in vivo detection method through the detection of 100 M serotonin in a mouse
model.
Finally, to mitigate the limitations of SERS and electrochemical detection methods, the
two techniques were combined. A carbon screen printed electrode was modified by dropcasting
AuNPs on the surface of the carbon working electrode. The redox process during an
electrochemical detection allows for the diffusion of the analyte to the surface of the modified
160

working electrode to aid in the localized SERS detection. SERS is then able to identify various
analytes, even with very similar oxidation potentials that are difficult to discern in
electrochemistry. The spectroelectrochemical detection of dopamine and DOPAC were obtained
where the two molecules are easily identified based on the molecular fingerprint obtained with
SERS.
Future directions for these projects include optimization of SERS based sensors for a
more selective detection. Conjugation of the nanoparticles with capture ligands such as
antibodies, aptamers, and boronic acids which selectively capture diols such as dopamine, would
allow for a more specific capture of target biomarker molecules for disease. SERS based sensors
which are specific to a target analyte would make the SERS detection in more complex mixtures
including human samples (CSF, blood, urine, saliva) feasible. SESORS detection should also be
optimized to include a more suitable brain mimic such as functioning slices of a mouse brain and
move toward the detection of neurochemicals in a mouse model. The SESORS detection has
been obtained through a rat and cat skull, both at ~2 mm thickness. The detection should be
extended to include thicker skulls that mimic the human skull which has a varying thickness of
3-14 mm. LODs should also be obtained of dopamine and DOPAC, as well as other dopamine
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